LONDON, UK / ACCESSWIRE / February 6, 2024 / Roquefort Therapeutics (LSE:ROQ)(OTCQB:ROQAF), the Main Market listed biotech company focused on developing first in class medicines in the high value and high growth oncology market, provides an update ...